These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 29915524)
41. Preliminary report of transmitted drug resistance to integrase strand chain transfer inhibitors in treatment-naïve HIV infected patients. Ferrer P; Ramos V; Puente MI; Afani A Diagn Microbiol Infect Dis; 2023 Dec; 107(4):116083. PubMed ID: 37778156 [TBL] [Abstract][Full Text] [Related]
42. Genetic Features of HIV-1 Integrase Sub-Subtype A6 Predominant in Russia and Predicted Susceptibility to INSTIs. Kirichenko A; Lapovok I; Baryshev P; van de Vijver DAMC; van Kampen JJA; Boucher CAB; Paraskevis D; Kireev D Viruses; 2020 Jul; 12(8):. PubMed ID: 32752001 [TBL] [Abstract][Full Text] [Related]
43. Variability of the HIV-1 3' polypurine tract (3'PPT) region and implication in integrase inhibitor resistance. Malet I; Delelis O; Nguyen T; Leducq V; Abdi B; Morand-Joubert L; Calvez V; Marcelin AG J Antimicrob Chemother; 2019 Dec; 74(12):3440-3444. PubMed ID: 31730161 [TBL] [Abstract][Full Text] [Related]
50. Analyses of HIV-1 integrase gene sequences among treatment-naive patients in the Eastern Cape, South Africa. Onoriode Digban T; Chucks Iweriebor B; Chikwelu Obi L; Nwodo U; Ifeanyi Okoh A J Med Virol; 2020 Aug; 92(8):1165-1172. PubMed ID: 31889319 [TBL] [Abstract][Full Text] [Related]
51. Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013-2016: Impact on susceptibility to first-line strategies including integrase strand-transfer inhibitors. Andreis S; Basso M; Scaggiante R; Cruciani M; Ferretto R; Manfrin V; Panese S; Rossi MC; Francavilla E; Boldrin C; Alvarez M; Dal Bello F; Mengoli C; Turriziani O; Sarmati L; Antonelli G; Andreoni M; Palù G; Parisi SG J Glob Antimicrob Resist; 2017 Sep; 10():106-112. PubMed ID: 28732792 [TBL] [Abstract][Full Text] [Related]
53. Successful Prevention of Transmission of Integrase Resistance in the Swiss HIV Cohort Study. Scherrer AU; Yang WL; Kouyos RD; Böni J; Yerly S; Klimkait T; Aubert V; Cavassini M; Battegay M; Hauser C; Calmy A; Schmid P; Bernasconi E; Günthard HF; J Infect Dis; 2016 Aug; 214(3):399-402. PubMed ID: 27130429 [TBL] [Abstract][Full Text] [Related]
54. HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV Prevention. Eshleman SH; Fogel JM; Halvas EK; Piwowar-Manning E; Marzinke MA; Kofron R; Wang Z; Mellors J; McCauley M; Rinehart AR; St Clair M; Adeyeye A; Hinojosa JC; Cabello R; Middelkoop K; Hanscom B; Cohen MS; Grinsztejn B; Landovitz RJ; J Infect Dis; 2022 Dec; 226(12):2170-2180. PubMed ID: 36240386 [TBL] [Abstract][Full Text] [Related]
55. Consensus HIV-1 subtype A integrase and its raltegravir-resistant variants: design and characterization of the enzymatic properties. Shadrina O; Krotova O; Agapkina J; Knyazhanskaya E; Korolev S; Starodubova E; Viklund A; Lukashov V; Magnani M; Medstrand P; Karpov V; Gottikh M; Isaguliants M Biochimie; 2014 Jul; 102():92-101. PubMed ID: 24594066 [TBL] [Abstract][Full Text] [Related]
56. HIV Type 1 Integrase Natural Polymorphisms in Viral Variants Circulating in FSU Countries. Lapovok I; Laga V; Kazennova E; Bobkova M Curr HIV Res; 2017 Nov; 15(5):318-326. PubMed ID: 28814231 [TBL] [Abstract][Full Text] [Related]
57. HIV-1 Integrase Resistance among Highly Antiretroviral Experienced Patients from Morocco. Alaoui N; El Alaoui MA; El Annaz H; Farissi FZ; Alaoui AS; El Fahime E; Mrani S Intervirology; 2019; 62(2):65-71. PubMed ID: 31307042 [TBL] [Abstract][Full Text] [Related]
58. Should We Be Testing for Baseline Integrase Resistance in Patients Newly Diagnosed With Human Immunodeficiency Virus? Koullias Y; Sax PE; Fields NF; Walensky RP; Hyle EP Clin Infect Dis; 2017 Oct; 65(8):1274-1281. PubMed ID: 28605418 [TBL] [Abstract][Full Text] [Related]
59. Portable Nanopore sequencing solution for next-generation HIV drug resistance testing. Park SY; Faraci G; Ganesh K; Dubé MP; Lee HY J Clin Virol; 2024 Apr; 171():105639. PubMed ID: 38219684 [TBL] [Abstract][Full Text] [Related]
60. Natural polymorphism of the HIV-1 integrase gene and mutations associated with integrase inhibitor resistance. Lataillade M; Chiarella J; Kozal MJ Antivir Ther; 2007; 12(4):563-70. PubMed ID: 17668566 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]